Prevalence, incidence and persistence of EB virus antibody in young adults.
about
Steroids for symptom control in infectious mononucleosisSteroids for symptom control in infectious mononucleosisX-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.Incidence, risk factors and outcomes of de novo malignancies post liver transplantationEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsAcute respiraotry diseases in students at the University of the Philippines, 1964-69ABO blood groups and viral diseasesSerologic studies of acute respiratory infections in military personnelChronic fatigue syndrome. A critical appraisal of the role of Epstein-Barr virusIdentification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virusHerpesviruses.Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.Epstein-Barr virus infectious mononucleosis.Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.The EB virus in relation to infectious mononucleosis.Effects of dialyzable transfer factor in patients with breast cancer.LMP1 strain variants: biological and molecular properties.Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.Unique nuclear DNA sequences in the involved tissues of Hodgkin's and Burkitt's lymphomasRNA related to that of a murine leukemia virus in Burkitt's tumors and nasopharyngeal carcinomas.Burkitt's tumors contain particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA.Aspects of Epstein-Barr virus infection in childhoodNatural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.Microbiome and malignancyPrimary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cellsEpstein-Barr virus infection in the neonatal period and in childhood.Analysis of the tumorigenic potential of common marmoset lymphoblastoid cells expressing a constitutively activated c-myc gene.Role of immunologic disturbance in human oncogenesis: some facts and fanciesEpstein-Barr virus antibody in cases and contacts of infectious mononucleosis; a family studyEpidemiological studies of Epstein-Barr herpesvirus infection in Western Australia.Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.EB virus antibody and infectious mononucleosis in a boarding school for boys.Measurement of heterophil antibody and antibodies to EB viral capsid antigen IgG and IgM in suspected cases of infectious mononucleosis.Immunological studies on Burkitt's lymphoma.Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.Potential selection of LMP1 variants in nasopharyngeal carcinoma.Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
P2860
Q24245428-6ABACB87-EA41-4143-BBE2-4D425AA6625FQ24248088-FB55C293-4184-43F7-B51B-4D1AD9D6D3E4Q24517035-1D6BBBED-A86C-4390-A9B1-8F7785F8E23AQ26748580-79FB34E9-E2C9-492F-944A-FE1666B98CD9Q27006548-6168351F-09B7-420F-975F-D4B907B207D8Q27486364-3C4D67ED-58D3-45F2-97E8-3B923ADC2287Q27487382-A44B893B-BAD0-49D8-9BDD-0621949C6215Q27487427-B45D63A1-DA62-4468-8FB7-DE9E2E29DE5FQ33616953-7D879D7E-4BE7-4562-852F-26F04BE35B96Q33835632-DCB20999-D76B-4BF7-9012-82B53E0869ADQ33847479-436B5025-DBD9-43A2-B87C-8EBC5B263E43Q33907657-22A0C245-72FE-421E-9352-27DBC1B95187Q34216257-A7E51901-7741-47F9-8365-8D5349C76B8CQ34228883-69B7A887-E035-4A1E-9973-13267309FB4EQ34302121-9A256423-EFCB-4261-A464-0A6531E21CDDQ34303153-A0492A12-29FA-45BB-9D7A-54345B914FC2Q34698721-9CC9CE3C-D5E8-4427-8F36-3F74EB5FA912Q34717145-58A4C94D-2BCA-4518-95FC-16DE81C57E5BQ34746549-9A5096DB-5306-4E13-8B37-3FC746EA1236Q34752119-D10584FB-CD9F-45C1-9EAF-829887339BB0Q35092921-80D24AE0-C1B4-408F-A459-4C193D0655A3Q35098237-5A8124B8-F81A-4266-9FF6-2C7D1BB17FBFQ35151035-38B0FEEE-2206-4804-B0FA-C8DEAEEBAB3AQ35178721-16B95EBF-80F5-40D6-A095-C3168F4EA1B0Q35688760-FF50BB85-70B5-4E71-843B-D832A434E660Q35857336-EDD330BE-00D7-490C-BF87-DE28EA5B98A6Q35938275-925BC82B-0E83-48AC-B6F5-4A011764E913Q35976927-9BF2A357-9DA6-4C84-8A94-4B89A97628EDQ36040087-7F9DA6B7-A9A3-4181-91D5-32B4E30BD1ECQ36251976-30C181C8-BC7B-49F9-AEFA-ABBB58C0406FQ36252243-60C5C9EC-5234-478D-ABA2-293CDC9E0DB6Q36335723-FD5C7BF0-8D87-444D-B9EB-FC4AD2B4BEE0Q36377385-FD49A3ED-A0E9-401E-89BA-686DED34E60CQ36595102-83DB9B5B-8F1F-4135-99D0-549213EF65B5Q36602271-B91EE983-AA2E-4349-B264-896A307F162CQ36771324-AD360F1E-06D1-4607-B97D-4F7CF644C45DQ36846242-E35CEBA7-4689-40DC-B61E-9E63BF7DF8A0Q36944141-8BCB4669-3A3B-4910-89BE-3D90918CBEE8Q36991541-D392E680-A14B-4435-8EA7-C71ECE840DE7Q36998049-BA657B33-F4B8-41BA-AE4E-B6E0334F43DF
P2860
Prevalence, incidence and persistence of EB virus antibody in young adults.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh-hant
name
Prevalence, incidence and persistence of EB virus antibody in young adults.
@en
Prevalence, incidence and persistence of EB virus antibody in young adults.
@nl
type
label
Prevalence, incidence and persistence of EB virus antibody in young adults.
@en
Prevalence, incidence and persistence of EB virus antibody in young adults.
@nl
prefLabel
Prevalence, incidence and persistence of EB virus antibody in young adults.
@en
Prevalence, incidence and persistence of EB virus antibody in young adults.
@nl
P2093
P1476
Prevalence, incidence and persistence of EB virus antibody in young adults.
@en
P2093
McCollum RW
Niederman JC
Subrahmanyan L
P304
P356
10.1056/NEJM197002122820704
P407
P577
1970-02-01T00:00:00Z